Cancer Epidemiology, Screening & Prevention

The Epidemiology of Cancer is the study of the factors affecting Cancer, as a way to conclude possible trends and causes. The study of Cancer Epidemiology uses Epidemiological Methods to discover the cause of Cancer and to recognize and develop improved treatments. This area of study must cope with problems of lead time bias and length time bias. Lead time bias is the theory that early diagnosis may artificially inflate the survival statistics of a Cancer, without really improving the natural history of the disease. Length bias is the concept that gentler growing, more lethargic Tumors are more likely to be identified by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs

Prevention or Preventive Healthcare means measures that are taken for Cancer Prevention. Cancer can be prevented by living a healthy lifestyle. A healthy lifestyle and regular screening exams help to reduce your risk for some types of Cancer.

Screenings can find Cancer early, when it’s most treatable. Cancer Screening aims to identify Cancer before symptoms appear. This may involve blood tests, urine tests, other tests, or Medical Imaging. The benefits of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed against any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a specific age group. Selective Screening identifies people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Global trends in Cancer Mortality and Incidence
  • Cancer Epidemiological studies: Principles, Statistics, Methodologies & Reporting
  • Cancer Epidemiological Risk factors
  • Cancer Screening, evaluation and intervention
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Cohort studies and Cancer Survival analysis

Related Conference of Cancer Epidemiology, Screening & Prevention

February 20-21, 2019 |

27th Annual Congress on Cancer Science and Targeted Therapies

San Francisco, USA
February 27-28, 2019

17th International Conference on Cancer Research and Therapy

Courtyard Marriott Seoul Times Square, Seoul, South Korea
March 4-5, 2019

24thAnnual meet on Surgical Oncology

Paris, France
March 07-08, 2019

32nd Euro Congress on Cancer Science & Therapy

Barcelona, Spain
March 20-21, 2019

10th Euro Breast Cancer Summit

| Paris, France
March 20-21, 2019

15 thGLOBAL BIOMARKERS SUMMIT

| Paris, France
April 08-09, 2019

3 rd World Congress on Radiology and Oncology

Abu Dhabi, UAE
April 29-30, 2019

33rd Global Experts Meeting onCancer Science & Therapy

Courtyard Marriott Seoul Times Square, Seoul, South Korea
May 06-07, 2019

International Conference on Frontiers in Lung Cancer

| Radisson Hotel Narita | Tokyo, Japan
May 6-7, 2019

3rd Global Summit on Oncology & Cancer

| Radisson Hotel Narita | Tokyo, Japan
May 09-10, 2019

15th World Congress on Blood Cancer

Amsterdam, Netherlands
May 13-14, 2019

16th Asia Pacific
Oncologists Annual Meeting

Holiday Inn Singapore Atrium, Singapore
July 15-16, 2019

23rd Global Annual Oncologists Meeting

Yokohama, Japan
July 19-20, 2019

Women Oncology Conference 2019

Atlanta, USA
September 13-14, 2019

31st Experts Meet On Cancer Therapy

| Holiday Inn Singapore Atrium | Singapore
October 10-11, 2019 |

37th World Cancer Conference

Dublin, Ireland
October 14-15, 2019

4th World Conference on Breast and Cervical Cancer

Helsinki, Finland
October 21-22, 2019

4th World Congress on Frontiers in Cancer Research and Therapy

Melbourne, Australia
November 11-12 2019

3rd Cancer Diagnostics & Treatment Conference

Frankfurt, Germany

Cancer Epidemiology, Screening & Prevention Conference Speakers

Recommended Sessions

Related Journals

Are you interested in